KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Evolent Health (EVH) Depreciation Expense (2016 - 2025)

Historic Depreciation Expense for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to $6.3 million.

  • Evolent Health's Depreciation Expense fell 1600.0% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.4 million, marking a year-over-year decrease of 1016.39%. This contributed to the annual value of $30.3 million for FY2024, which is 648.15% down from last year.
  • Latest data reveals that Evolent Health reported Depreciation Expense of $6.3 million as of Q3 2025, which was down 1600.0% from $6.4 million recorded in Q2 2025.
  • In the past 5 years, Evolent Health's Depreciation Expense ranged from a high of $8.9 million in Q4 2022 and a low of $6.3 million during Q3 2025
  • For the 5-year period, Evolent Health's Depreciation Expense averaged around $7.6 million, with its median value being $7.6 million (2021).
  • In the last 5 years, Evolent Health's Depreciation Expense skyrocketed by 1470.59% in 2021 and then tumbled by 1898.73% in 2025.
  • Over the past 5 years, Evolent Health's Depreciation Expense (Quarter) stood at $7.8 million in 2021, then grew by 14.1% to $8.9 million in 2022, then decreased by 14.61% to $7.6 million in 2023, then fell by 2.63% to $7.4 million in 2024, then fell by 14.86% to $6.3 million in 2025.
  • Its Depreciation Expense was $6.3 million in Q3 2025, compared to $6.4 million in Q2 2025 and $7.3 million in Q1 2025.